Oren Dan

CIK 00016367017 companiesOR AKIVA, L3

SEC Profile

Transactions

Companies

Filings

CIK

0001636701

Recent Transactions

42 trades

Purchase
Roivant Sciences Ltd.$ROIV
Common Shares
2022-11-10$5.00/sh+4,000,000→ 102,849,443 total
Purchase
Roivant Sciences Ltd.$ROIV
Common Shares
2022-04-25$3.91/sh+8,600→ 98,849,443 total
Purchase
Roivant Sciences Ltd.$ROIV
Common Shares
2022-04-22$3.83/sh+31,685→ 98,840,843 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2021-06-03$2.25/sh−857,506→ 3,637,314 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2021-06-02$2.56/sh−61,211→ 4,494,820 total
Sale
Intec Pharma Ltd.
Ordinary Shares
2020-02-04$0.29/sh−110,000→ 4,234,897 total
Sale
Intec Pharma Ltd.
Ordinary Shares
2020-02-03$0.32/sh−80,000→ 4,344,897 total
Sale
Intec Pharma Ltd.
Ordinary Shares
2020-01-31$0.31/sh−725,951→ 4,424,897 total
Purchase
Urovant Sciences Ltd.
Common Shares
2019-06-19$8.17/sh+4,957→ 22,860,013 total
Purchase
Urovant Sciences Ltd.
Common Shares
2019-06-18$8.21/sh+6,706→ 22,855,056 total
Purchase
Urovant Sciences Ltd.
Common Shares, $0.000037453 par value per share
2019-06-17$8.53/sh+6,541→ 22,848,350 total
Purchase
Urovant Sciences Ltd.
Common Shares
2019-06-14$7.91/sh+7,144→ 22,841,809 total
Purchase
Urovant Sciences Ltd.
Common Shares
2019-06-13$7.95/sh+7,367→ 22,834,665 total
Purchase
Urovant Sciences Ltd.
Common Shares, $0.000037453 par value per share
2019-06-12$8.30/sh+7,500→ 22,827,298 total
Purchase
Urovant Sciences Ltd.
Common Shares
2019-06-11$8.58/sh+7,189→ 22,819,798 total
Purchase
Urovant Sciences Ltd.
Common Shares
2019-06-10$8.35/sh+7,500→ 22,812,609 total
Purchase
Urovant Sciences Ltd.
Common Shares, $0.000037453 par value per share
2019-06-07$7.96/sh+6,649→ 22,805,109 total
Purchase
Urovant Sciences Ltd.
Common Shares
2019-06-06$8.00/sh+7,082→ 22,798,460 total
Purchase
Urovant Sciences Ltd.
Common Shares
2019-06-05$8.02/sh+6,540→ 22,791,378 total
Purchase
Urovant Sciences Ltd.
Common Shares, $0.000037453 par value per share
2019-06-04$7.59/sh+7,500→ 22,784,838 total
Purchase
Myovant Sciences Ltd.
Common Shares, $0.000017727 par value per share
2019-06-04$8.25/sh+2,424,242→ 40,765,599 total
Purchase
Urovant Sciences Ltd.
Common Shares
2019-06-03$7.71/sh+5,424→ 22,777,338 total
Purchase
Urovant Sciences Ltd.
Common Shares
2019-05-31$7.70/sh+5,071→ 22,771,914 total
Purchase
Urovant Sciences Ltd.
Common Shares, $0.000037453 par value per share
2019-05-30$7.97/sh+6,951→ 22,766,543 total
Purchase
Urovant Sciences Ltd.
Common Shares
2019-05-30$8.91/sh+300→ 22,766,843 total
Purchase
Urovant Sciences Ltd.
Common Shares
2019-05-29$7.55/sh+6,882→ 22,759,592 total
Purchase
Urovant Sciences Ltd.
Common Shares
2019-05-28$7.68/sh+3,807→ 22,752,710 total
Purchase
Urovant Sciences Ltd.
Common Shares, $0.000037453 par value per share
2019-05-24$7.70/sh+3,796→ 22,748,903 total
Purchase
Urovant Sciences Ltd.
Common Shares
2019-05-23$7.76/sh+4,802→ 22,745,107 total
Purchase
Urovant Sciences Ltd.
Common Shares, $0.000037453 par value per share
2019-05-22$8.06/sh+5,033→ 22,740,305 total
Purchase
Urovant Sciences Ltd.
Common Shares, $0.000037453 par value per share
2019-05-21$8.52/sh+9,995→ 22,735,272 total
Purchase
Urovant Sciences Ltd.
Common Shares
2019-05-20$8.39/sh+1,715→ 22,725,277 total
Purchase
Urovant Sciences Ltd.
Common Shares, $0.000037453 par value per share
2019-05-20$7.98/sh+8,285→ 22,723,562 total
Purchase
Urovant Sciences Ltd.
Common Shares
2019-05-17$7.36/sh+6,200→ 22,715,277 total
Purchase
Urovant Sciences Ltd.
Common Shares, $0.000037453 par value per share
2019-05-16$6.79/sh+5,408→ 22,709,077 total
Purchase
Sio Gene Therapies Inc.
Common Shares, $0.00001 par value per share
2019-03-18$1.50/sh+6,666,667→ 105,952,381 total
Purchase
Sio Gene Therapies Inc.
Common Shares, $0.00001 par value per share
2018-12-18$1.00/sh+10,000,000→ 99,285,714 total
Purchase
Urovant Sciences Ltd.
Common Shares, $0.000037453 par value per share
2018-10-01$14.00/sh+2,678,571→ 22,703,669 total
Purchase
Sio Gene Therapies Inc.
Common Shares, $0.00001 par value per share
2018-06-05$1.75/sh+14,285,714→ 89,285,714 total
Purchase
Myovant Sciences Ltd.
Common Shares, $0.000017727 par value per share
2018-04-02$20.27/sh+1,110,015→ 38,341,357 total
Purchase
Arbutus Biopharma Corp$ABUS
Series A Participating Convertible Preferred Shares
2018-01-12$100.00/sh+664,000→ 1,164,000 total
Purchase
Arbutus Biopharma Corp$ABUS
Series A Participating Convertible Preferred Shares
2017-10-16$100.00/sh+500,000→ 500,000 total

Companies

Recent Filings

Address

1 DEXCEL STREET

OR AKIVA, L3, 30600000

View on SEC.gov